Cotinga Pharmaceuticals Inc.
OTC: COTQF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard T. Ho
- Headquarters
- Toronto, Canada
- IPO year
- 2009
- Market cap
- $2.2K
- Website
- https://www.cotingapharma.com
Loading COTQF…
Loading profile data…Frequently asked questions about COTQF
What does Cotinga Pharmaceuticals Inc. (COTQF) do?
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-...
Where does COTQF trade?
Cotinga Pharmaceuticals Inc. (COTQF) trades on the Other OTC.
What sector is COTQF in?
Cotinga Pharmaceuticals Inc. (COTQF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cotinga Pharmaceuticals Inc.?
Richard T. Ho is the chief executive officer of Cotinga Pharmaceuticals Inc. (COTQF).
Where is Cotinga Pharmaceuticals Inc. headquartered?
Cotinga Pharmaceuticals Inc. is headquartered in Canada.
Does COTQF pay a dividend?
Cotinga Pharmaceuticals Inc. (COTQF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COTQF go public?
Cotinga Pharmaceuticals Inc. (COTQF) completed its initial public offering in 2009.